ir.iderapharma.com ir.iderapharma.com

ir.iderapharma.com

Investors and Media | Investor Relations | Idera Pharmaceuticals

Skip to main content. Portfolio of Strategic Patents. Key Presentations and Publications. Idera is advancing to the clinic in autoimmune diseases and certain genetically defined forms of B-cell lymphoma: activated B-cell like diffuse large B-cell lymphoma (ABC-DLBCL), Waldenström’s macroglobulinemia and others. Its lead drug candidate, IMO-8400, is designed to modulate immune responses through Toll-like receptors (TLRs). Idera to Present at the 2015 Wedbush PacGrow Healthcare Conference. Replication or r...

http://ir.iderapharma.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.IDERAPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 12 reviews
5 star
6
4 star
0
3 star
4
2 star
0
1 star
2

Hey there! Start your review of ir.iderapharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT IR.IDERAPHARMA.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investors and Media | Investor Relations | Idera Pharmaceuticals | ir.iderapharma.com Reviews
<META>
DESCRIPTION
Skip to main content. Portfolio of Strategic Patents. Key Presentations and Publications. Idera is advancing to the clinic in autoimmune diseases and certain genetically defined forms of B-cell lymphoma: activated B-cell like diffuse large B-cell lymphoma (ABC-DLBCL), Waldenström’s macroglobulinemia and others. Its lead drug candidate, IMO-8400, is designed to modulate immune responses through Toll-like receptors (TLRs). Idera to Present at the 2015 Wedbush PacGrow Healthcare Conference. Replication or r...
<META>
KEYWORDS
1 careers
2 search this site
3 sections
4 about idera
5 leadership team
6 board of directors
7 clinical advisory board
8 pipeline
9 b cell lymphomas
10 rare diseases
CONTENT
Page content here
KEYWORDS ON
PAGE
careers,search this site,sections,about idera,leadership team,board of directors,clinical advisory board,pipeline,b cell lymphomas,rare diseases,our clinical programs,our scientific platforms,our science,intellectual property,investors and media,site map
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investors and Media | Investor Relations | Idera Pharmaceuticals | ir.iderapharma.com Reviews

https://ir.iderapharma.com

Skip to main content. Portfolio of Strategic Patents. Key Presentations and Publications. Idera is advancing to the clinic in autoimmune diseases and certain genetically defined forms of B-cell lymphoma: activated B-cell like diffuse large B-cell lymphoma (ABC-DLBCL), Waldenström’s macroglobulinemia and others. Its lead drug candidate, IMO-8400, is designed to modulate immune responses through Toll-like receptors (TLRs). Idera to Present at the 2015 Wedbush PacGrow Healthcare Conference. Replication or r...

LINKS TO THIS WEBSITE

iderapharma.com iderapharma.com

Intellectual Property - Idera Pharmaceuticals

http://www.iderapharma.com/our-science/intellectual-property

Toll-Like Receptor Immune Modulation. Pipeline & Programs. Protecting discoveries to continue work into the future. Our scientists have extensive experience with designing and creating nucleic acid compounds for therapeutic applications. Based on our pioneering insights, we have created nucleic acid constructs that act as antagonists of toll-like receptors (TLRs), agonists of TLRs, and gene silencing oligonucleotides (GSOs) or antisense compounds. We protect our discoveries using a variety of methods, in...

iderapharma.com iderapharma.com

Rare Diseases - Idera Pharmaceuticals

http://www.iderapharma.com/rare-diseases

Toll-Like Receptor Immune Modulation. Pipeline & Programs. Committed to serving patients in key areas of unmet medical need. Rare diseases can afflict anyone, at any age. They can be acute or chronic. Many are debilitating, while others are unavoidably fatal, given current medical options. Approved therapies are available to treat hundreds of these conditions, but most have no curative or disease-modifying treatment options. Learn more about the debilitating effects of dermatomyositis.

iderapharma.com iderapharma.com

Careers - Idera Pharmaceuticals

http://www.iderapharma.com/careers

Toll-Like Receptor Immune Modulation. Pipeline & Programs. Great people to work with. That’s our target. At Idera, our vision is to translate scientific breakthroughs into important new medicines. We have a culture where patients are at the center of all we do, with core Idera values that connect us to each other and our stakeholders and define who we are, what we stand for, and how we work. Values we embrace and seek in our new employees:. Learn More About Idera’s Values. Short- and long-term disability...

iderapharma.com iderapharma.com

Pipeline & Programs - Idera Pharmaceuticals

http://www.iderapharma.com/pipeline

Toll-Like Receptor Immune Modulation. Pipeline & Programs. Pipeline & Programs. Advancing a deep and diverse clinical-stage pipeline. Our lead product candidate, IMO-8400, has a novel mechanism of action as an antagonist to toll-like receptors (TLRs) 7, 8, and 9 and has demonstrated tolerability and clinical activity in a Phase 2 trial of patients with an autoimmune disease. IMO-8400 for Genetically Defined Forms of B-cell Lymphoma. In 2014, Idera initiated a partnership with Abbott Molecular to develop ...

UPGRADE TO PREMIUM TO VIEW 6 MORE

TOTAL LINKS TO THIS WEBSITE

10

OTHER SITES

ir.icscanada.edu ir.icscanada.edu

Home - Institute for Christian Studies Repository

The ICS Library welcomes you to our Institutional Repository, where you can explore our digital collections. The repository facilitates access to our research, creative works, and publications by collecting, sharing and archiving content selected and deposited by our faculty, graduate students and staff. Thank you for visiting the ICS Repository! Please donate online at. If you need more information please send an email to. Van der Hoef, Steve. Art, the Bible and. Thinking Deeply About Our Faith. Except ...

ir.icumed.com ir.icumed.com

Investor Relations | ICU Medical

Skip to main navigation. ICU Medical MedNet Safety Software. IV Solutions and Irrigation. Hazardous Drug Closed Systems and CSTDs. Cardiac Output Monitoring Sensors and Catheters. TriOx Venous Oximetry Catheters. Thermodilution and Monitoring Catheters. Closed Blood Sampling and Conservation. Accurate, Safe, and Efficient Drug Compounding. Safe Handling Made Simple. Less Waste, Lower Cost. Cost-Effectively Comply With USP800 CSTD Guidelines. Enhance Surgical Recovery by Optimizing Fluid Balance.

ir.id-systems.com ir.id-systems.com

I.D. Systems | Overview

160; 0.07. Data as of 01/12/17 1:46 pm ET. Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources. Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources. Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources. ID Systems to Present at the 19th Annual Needham Growth Conference on January 11, 2017. ID Systems Appoints Chris Wolfe as New Chief Executive Officer. ID Systems Reports Third Quarter 2016 Results. WOODCLIFF LAKE,...

ir.ide.go.jp ir.ide.go.jp

Home: Academic Research Repository at the Institute of Developing Economies,Japan(ARRIDE)

Academic Research Repository at the Institute of Developing Economies,Japan(ARRIDE). Welcome to Our ARRIDE. ARRIDE is the system of Institutional Repository to collect, preserve, and disseminate IDE’s research output regarding developing countries and regions. You can read the full text of articles written by IDE researchers. アジア経済=Asian Economies (in Japanese, Monthly) 、 The Developing Economies (in English, Quarterly) の査読済み論文、 現代の中東=The Contemporary Middle East (in Japanese, Biannually) の論文.

ir.idealpower.com ir.idealpower.com

Ideal Power | Overview

Ideal Power in the News. View all Financial Results. Ideal Power's Power Conversion System Selected by Sonnenbatterie for Their Commercial Energy Storage Solutions. Ideal Power Inc. Announces Second Quarter 2015 Results. KACO new energy to Provide Battery Converters and Energy Storage Systems Using Ideal Power's Power Conversion Systems. View all Press Releases. September 14 - September 17, 2015. Energy Storage North America. October 13 - October 15, 2015. Corporate Stock Transfer, Inc. Denver, CO 80209.

ir.iderapharma.com ir.iderapharma.com

Investors and Media | Investor Relations | Idera Pharmaceuticals

Skip to main content. Portfolio of Strategic Patents. Key Presentations and Publications. Idera is advancing to the clinic in autoimmune diseases and certain genetically defined forms of B-cell lymphoma: activated B-cell like diffuse large B-cell lymphoma (ABC-DLBCL), Waldenström’s macroglobulinemia and others. Its lead drug candidate, IMO-8400, is designed to modulate immune responses through Toll-like receptors (TLRs). Idera to Present at the 2015 Wedbush PacGrow Healthcare Conference. Replication or r...

ir.idreamsky.com ir.idreamsky.com

iDreamSky :: Investors :: Investor Home

Company Presentation - August 2015. IDreamSky Technology Limited Second Quarter 2015 Financial Results. IDreamSky Technology Limited Announces Completion of Going Private Transaction. IDreamSky Technology Limited Announces Shareholders Vote to Approve Going Private Transaction. IDreamSky Filed Its Annual Report on Form 20-F. IDreamSky Announces Extraordinary General Meeting of Shareholders. Data as of 09/07/16 4:00 pm ET. Minimum 20 minute delay. Mergers and Acquisition Announcement. HQ shenzhen, china.

ir.idsse.ac.cn ir.idsse.ac.cn

中国科学院深海科学与工程研究所机构知识库(IDSSE OpenIR): Home

Have you forgotten your password? Journal of. [6]. Chinese jo. [5]. This work . [1]. UNDERWATER NAVIGATION AND CALIBRATION OF. [期刊论文, 2016-12]. Climate variations of Central Asia on or. [期刊论文, 2016-12]. Submarine slide evidence for late Miocen. [期刊论文, 2016-12]. Mineralogical, crystallographic, and iso. [期刊论文, 2016-12]. 深海信息监测快报第12期 [深海信息监测快报, 2016-12]. Three dimensional seismic studies of dee. [期刊论文, 2016-12]. Influence of subduction components on ma. [期刊论文, 2016-12]. Preface [期刊论文, 2016-12].

ir.idt.com ir.idt.com

Investor Relations | Integrated Device Technology, Inc.

Skip to main navigation. Https:/ my.idt.com. IDT develops a broad range of low-power, high-performance mixed-signal semiconductor solutions that optimize our customers' applications in key markets. Integrated Device Technology, Inc. IDT Completes 200G/400G Intra- and Inter- Datacenter Applications With Introduction of HXR14x00 and HXR44x00 TIAs. IDT Accelerates the Move to 5G with New 25G Linear Driver. IDT to Showcase Best-in-Class 64G Linear Driver for Coherent Applications at OFC 2018. Newest, Highest...

ir.idt.net ir.idt.net

Overview

Back to IDT.net. IDT Corporation (NYSE: IDT) provides retail communications, payment and money transfer services primarily under its flagship Boss Revolution. Brand, and cloud-based telecommunications services to businesses through its Net2Phone offerings. IDT's wholesale telecommunications business is a leading global carrier of international long distance voice calls.

ir.iexim.org ir.iexim.org

IR Portal

USPTO 11/264083; U.S.PTO 11/419244, U.S.PTO 11/419220 and many others in Paris Convention for the Protection of Industrial Properties. Any Time, Any Place Technology. Welcome to World Fashion Organization. USPTO 11/264083; U.S.PTO 11/419244, U.S.PTO 11/419220 and many others in Paris Convention for the Protection of Industrial Properties.